1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Alveolar Bone Atrophy in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The analysis of alveolar bone loss was performed 3 weeks after surgery by scanning the microradiographic films of the mandible cross-sections." | 1.33 | Topical application of drugs influencing cytoskeleton and cell contractility affects alveolar bone loss in rats. ( Bahar, H; Binderman, I; Yaffe, A, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yaffe, A | 1 |
| Bahar, H | 1 |
| Binderman, I | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Topical application of drugs influencing cytoskeleton and cell contractility affects alveolar bone loss in rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alveolar Bone Loss; Analysis of Variance; Animals; Ch | 2006 |